‘Gut-on-chip’ can predict immunotherapy outcomes for melanoma patients

A team of researchers has developed a “gut-on-chip” (a miniature model of the human intestine on a chip-sized device) capable of reproducing the main features of intestinal inflammation and of predicting the response of melanoma patients to immunotherapy treatment. The results have just been published in Nature Biomedical Engineering.

Leave A Comment

Your email address will not be published. Required fields are marked *